Friday, 16 April 2021

Inspire files for $86.25M IPO

09 April 2018 | Company results

The company plans to list on the NYSE under the symbol INSP.

Singapore - The Maple Grove-based company, Inspire Medical Systems, which sells its proprietary Inspire therapy for sleep apnea, has filed for an initial public offering seeking up to $86.25M.

BofA Merrill Lynch and Goldman Sachs are the joint bookrunners on the deal. For the year ended Dec. 31, 2017, the company posted $28.6M in revenue, with $22.55M of that going through as gross profit.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account